Continuing Education Activities

Here at JADPRO CE, you can find a valuable array of certified educational opportunities: it’s the place to get your credits and update your learning in oncology. We provide advanced practitioners like you with a wide range of continuing education, covering the most current topics in several formats so you can choose the way you want to learn. You'll find that our CE offerings are easy to navigate. You can sort by topic and/or format, or simply browse the site and get started!

Topic

Format

      Quick Tips →

Thoracic Cancer
NSCLC
Webcast

Approaches for Optimal Molecular Testing, Treatment, and Management of NSCLC and Accompanying Driver Mutations

Posted: October 18, 2021 / Expires: December 31, 2022

Estimated time to complete: 1.25 hours

CLL
Adverse Event Management
Webcast

CLL/SLL: Managing Adverse Events Associated with BTK Inhibitor Therapy

Posted: October 18, 2021 / Expires: December 31, 2022

Estimated time to complete: 1.25 hours

Bladder Cancer
Novel Therapy
Webcast

Navigating the Expanding Treatment Landscape in Metastatic Urothelial Cancer: Novel Targeted Therapies

Posted: October 18, 2021 / Expires: December 31, 2022

Estimated time to complete: 1.25 hours

Prostate Cancer
Novel Therapy
Webcast

Navigating the Evolving Treatment Landscape in Prostate Cancer: A Focus on Novel Anti-androgen Therapy

Posted: October 18, 2021 / Expires: December 31, 2022

Estimated time to complete: 1.25 hours

HER2 Positive Breast Cancer
Breast Cancer
Webcast

Metastatic HER2-Positive Breast Cancer: Newer and Emerging Treatment Considerations and Personalized Therapies

Posted: October 18, 2021 / Expires: December 31, 2022

Estimated time to complete: 1.25 hours

Kidney Damage
Adverse Event Management
Video

Clinical Updates in Acute Kidney Injury: Improving Outcomes for Patients Treated with High-Dose Methotrexate

In this CE/CME-certified activity, you'll find a case-based interactive module on the safe and effective use of approved therapies to manage acute kidney injury associated with high-dose methotrexate.

Posted: December 09, 2020 / Expires: December 08, 2022

Estimated time to complete: 0.5 hour

Breast Cancer
Oral Therapies
Print

CDK4/6 Inhibitors: Paving the Way for HR-Positive, HER2-Negative Early Breast Cancer

This activity will review the latest emerging evidence for CDK4/6 inhibitors in the adjuvant setting for early breast cancer. Interprofessional perspectives and recommendations for improving adherence and side effect management will be featured.

Posted: November 17, 2021 / Expires: November 16, 2022

Estimated time to complete: 0.5 hour

Novel Therapy
Print

Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life

This educational activity reviews currently approved prophylaxis therapy in hemophilia A, the benefits of prophylaxis and adherence, and patient quality-of-life factors. Interprofessional perspectives from an expert faculty panel are featured.

Posted: May 25, 2022 / Expires: May 24, 2023

Estimated time to complete: 0.5 hour

Multiple Myeloma
Print

Multiple Myeloma and Plasma Cell Disorders: Update on Diagnosis, Prognosis, Treatment, and Supportive Care

Developed by members of the International Myeloma Foundation (IMF) Nurse Leadership Board, this supplement contains case studies demonstrating clinical decision-making and reflecting the latest updates in managing multiple myeloma and plasma cell disorders.

Posted: June 30, 2022 / Expires: July 1, 2023

Estimated time to complete: 2.5 hours

Copyright © 2010-2022 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.